Status:

UNKNOWN

The Effect of Electroacupuncture (EA) on the Success of Inferior Alveolar Nerve Block (IANB) and Post-operative Pain Relief in Mandibular Molar With Symptomatic Irreversible Pulpitis (SIP) Among Malaysians: A Study Protocol for Randomized Double-Blinded Clinical Pilot Study

Lead Sponsor:

IMU University, Malaysia

Conditions:

Symptomatic Irreversible Pulpitis (SIP)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Acupuncture is recognized for its pain relief effect. Electroacupuncture(EA) is a form of acupuncture where electric current is passed between pairs of acupuncture needles in order to achieve therapeu...

Detailed Description

A randomized double-blinded clinical pilot study will be conducted in an IMU Oral Health Centre, registered under Malaysia local authority. Convenient stratified blocked random sampling method will be...

Eligibility Criteria

Inclusion

  • All Malaysians above the age of 18 years old having a restorable first or second mandibular molar with symptomatic irreversible pulpitis and a history of spontaneous pain presenting with pain level above 54 mm using 170 mm Heft-Parker visual analogue scale (HP-VAS).

Exclusion

  • Patient with severe systemic disorders, mental disorders, seizures or epilepsy, heart disease, severe clotting disorders, severe periodontal disease or a widening of the periodontal ligament space or periapical radiolucency.
  • Patient having a pacemaker.
  • Pregnant or lactating women.
  • Patient who is true needle phobia \[51\].
  • Patient who has a malignant tumor, wound, infection, lymphedema or fracture at electroacupuncture site.
  • Patient who is sensitive to mepivacaine and paracetamol.
  • Patient who has a history of treatment with acupuncture, or using any type of medication that could affect the current perception of pain such as tricyclic antidepressants, selective serotonin reuptake inhibitors, analgesics, corticosteroids, or antibiotic at least 24 hours before the endodontic therapy.

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04804761

Start Date

January 1 2023

End Date

July 31 2024

Last Update

March 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

International Medical University

Kuala Lumpur, Malaysia, 57000